Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 387

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1A
Chunk 387
---
otechnology product candidates, which could make it difficult for us to stop the infringement of our patents or marketing of competing
product candidates in violation of our proprietary rights generally. Proceedings to enforce our patent rights in other jurisdictions,
whether or not successful, could result in substantial costs and divert our efforts and attention from other aspects of our business,
could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could
provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies
awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world
may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.

Many countries, including European Union countries, India, Japan and
China, have compulsory licensing laws under which a patent owner may be compelled under specified circumstances to grant licenses to third
parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In those
countries, we may have limited remedies, which could materially diminish the value of those patents. This could limit our potential revenue
opportunities. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant
commercial advantage from the intellectual property that we develop or license.

If we are unable to protect the confidentiality of any trade
secrets, our business and competitive position would be harmed.

In addition to seeking patents for any product candidates, we may rely
on trade secrets, including know-how, technology and other proprietary information, to maintain our competitive position. We seek to protect
this information, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them,
such as our employees, corporate collaborators, outside scientific collaborators, contract manufacturers, consultants, advisors and other
third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants.

Because we rely and expect to continue to rely on third parties to
manufacture our product candidates and future product candidates, and we collaborate and expect to continue to collaborate with third
parties on the development of current and future product candidates, we must, at times, share trade secrets with them. If we conduct joint
research and development programs, we may be required to share trade secrets under the terms of our research and development partnerships
or similar agreements. We seek to protect our proprietary technology